Hence, further research is necessary to elucidate the molecular mechanisms underlying aberrant Mcl-1 splicing by targeting these splicing factors in GC and understand the potential role of Mcl-1 mRNA splicing in GC therapy. The gene discussed is MCL1; the disease is gastric cancer.